Back

Efficacy and safety results of a novel small-diameter defibrillation lead by race and age: lead evaluation for defibrillation and reliability (LEADR) trial analysis

31 August 2025 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Cardiac implantable electronic device therapy Implantable Cardioverter-Defibrillator (ICD) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Pamela Mason

University of Virginia Medical Center, Charlottesville (United States of America)

4 More presentations in this session

Presentation thumbnail
Piezoelectric energy harvesting for leadless pacing: a novel inertial energy harvester tuned to cardiac dynamics
Professor V. Reddy (New York City, US)
Abstract Slides Video
Presentation thumbnail
Pacing strategies for atrioventricular block: a comparison of leadless, his bundle, and right ventricular stimulation
Doctor A. Bagatin (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Global left ventricular myocardial work efficiency in left bundle branch pacing versus right ventricular pacing: results of an observational study. An extended 2-year follow up.
Doctor E. Papastavrou (Patra, GR)
Abstract Slides Video
Presentation thumbnail
A call to move away from 'out of the box' programming for cardiac resychronisation therapy (CRT) - an observational analysis of rate adaptive pacing in the United States.
Doctor S. Kamalathasan (Leeds, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac implantable electronic device therapy

The Event

Event poster

ESC Congress 2025

31 August 2025 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Regional results of the lead evaluation for defibrillation and reliability (LEADR) trial
thumbnail
Congress Presentation
Early performance of a novel small diameter lumenless OmniaSecure defibrillation lead in the pediatric population
thumbnail
Congress Presentation
Safety and performance of a novel defibrillation lead placed in the left bundle branch area: primary results of the LEADR LBBAP clinical trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources